We Cannot Step Into the Same River Twice: A claim-by-claim response to David Sinclair’s series of interviews on aging, disease, and reprogramming

This article is a direct response to David Sinclair’s series of interviews on the Information Theory of Aging, aging as disease, and cellular reprogramming as an anti-aging strategy. Across multiple conversations—in podcasts, talks, and public discussions—Sinclair has consistently advanced the same core claims: aging is an information problem, aging should be treated as a disease, and cellular reprogramming can reverse aging itself.

David Sinclair has made important contributions to geroscience through work on sirtuins, NAD-related pathways, epigenetic regulation, and the Information Theory of Aging. The purpose of this response is not to dismiss those contributions, but to read the same interviews through a different physiological and philosophical lens: the organism lives one continuous individual biological program from birth to natural death, always immersed in environment, and aging is one natural phase of that life cycle rather than a disease in itself.

That difference in starting point changes how the same claims are interpreted, how research questions are framed, how interventions are designed, and how medicine understands success or failure. A claim-by-claim comparison makes those differences clearer than a broad essay because it separates what Sinclair says, how it is read here, and what each interpretation means for the science and practice of aging research.

Claim 1: Aging is fundamentally an information problem

David Sinclair's claim

Across his interviews, Sinclair's Information Theory of Aging argues that aging is driven by progressive loss of youthful epigenetic information, while the DNA sequence remains largely intact. In this framework, cells gradually lose the ability to read the right genes at the right time, and this informational loss becomes a central explanation for aging phenotypes.

A different reading

This response reads that idea as important but incomplete. Living organisms have always interacted with and been shaped by information in many forms: chemical gradients, oxygen concentration, nutrients, hormones, immune signals, mechanical forces, and social signals. Epigenetic information is therefore not the whole informational reality of life, but one channel within a much wider, multilayered system that operates continuously across the entire life course.

From this perspective, the organism should be understood first as a whole person executing one uninterrupted individual biological program from birth to death, not as an aggregate of cells whose age can be fully explained by one molecular language. Aging is then read not as the collapse of life into error, but as one phase of an ongoing developmental continuum in which different informational languages remain active and interdependent.

What this difference means for science

If aging is treated primarily as epigenetic information loss, research will naturally prioritize molecular clocks, chromatin state, and gene-expression control as the main explanatory axis. If aging is treated as one phase of a whole-organism program immersed in environment, research must also give equal weight to physiology, systems regulation, developmental history, ecological exposures, and person-level variability across the life cycle.

The practical consequence is significant. Sinclair's framing encourages a search for master molecular levers, while the broader physiological framing encourages integrative models that connect molecular data with tissue regulation, organism-level adaptation, and environmental context. The second approach is less reductionist and may better explain why similar molecular signatures can lead to very different functional outcomes in real human beings.

Claim 2: Aging is a disease

David Sinclair's claim

Across multiple interviews, Sinclair and other advocates of geroscience have argued that aging should be treated as a disease process because it drives morbidity, loss of function, and vulnerability to chronic disorders. This position is often presented as strategically useful because disease classification could accelerate trials, regulation, and intervention development targeting aging biology.

A different reading

This response disagrees with that declaration. Aging is better understood as a natural phase of the individual's biological program, as physiologically legitimate as growth, puberty, adulthood, and natural death. The organism does not leave normal biology and enter pathology when it ages; it continues the same life program under changing internal reserves and lifelong environmental influences.

A disease is usually understood as a deviation from expected physiological organization or function, whereas aging is universal, species-typical, and built into the life cycle itself. The existence of healthy aging further supports this distinction, because preserved function into advanced age shows that aging and disease are related but not identical realities.

What this difference means for study and implementation

If aging is classified as a disease, science and medicine may begin to treat the life cycle itself as pathology. That shift can be powerful politically and commercially, but it can also distort research priorities by pushing the field toward defeating aging rather than protecting the integrity of aging as a physiological phase of life.

If aging is viewed instead as a normal phase of the personal biological program, then the research priority changes: the task becomes identifying why some people move through this phase with relative integrity while others accumulate harmful disruptions. Clinical implementation also changes, because the goal becomes supporting function, resilience, and adaptive reserve across the lifespan rather than framing the mere fact of aging as itself diseased.

Claim 3: Cellular reprogramming can reverse aging

David Sinclair's claim

A major implication of Sinclair's framework, repeated across his interviews, is that if epigenetic information can be restored, cellular age may be partially reset, opening the way to anti-aging therapies based on reprogramming. This idea is connected to the broader hope that restoring youthful gene regulation could reverse dysfunction in aged tissues and ultimately reverse aging itself.

A different reading

This response accepts the promise of reprogramming at the cellular level, but questions the leap from cells to the living person. A reprogrammed cell in a dish or even in a selected tissue is not equivalent to an organism whose cells exist within complex hormonal, neural, immune, structural, and intercellular regulation. The body is not a simple sum of cells; it is an integrated regulatory architecture that continuously constrains what any individual cell can become or do — and that architecture carries the full developmental and environmental history of the whole person from birth to their current moment in the life cycle.

For that reason, restoring youthful features in cells does not automatically restore the whole person's stage within the life cycle. Reprogrammed cells must still function within thresholds set by genetic individuality, developmental history, sex, tissue structure, environmental exposure, and the current state of systemic regulation. The regulatory environment into which those cells are returned is not neutral — it reflects the ongoing individual biological program of that specific person, at that specific phase of their life.

A related strategy — replacing damaged or depleted cells with healthy cambial stem cells — is more physiologically grounded and deserves separate attention. A healthy stem cell population introduced into damaged tissue can generate successive generations of functional daughter cells, gradually restoring tissue quality and improving function over time. This is a legitimate and already clinically productive direction in regenerative medicine. However, even here the individual biological program asserts its boundaries. The introduced stem cells do not act freely — they enter a tissue environment shaped by the organism's hormonal state, immune activity, extracellular matrix architecture, local paracrine signals, and systemic regulatory balance. The quality and extent of regeneration those cells can produce is therefore not determined by the cells alone, but by the integrated biological individuality of the whole person.

What is deeply important to recognize is that even in this intervention, we are not inventing something new or foreign to the organism. We are copying what Nature itself does — replacing worn components with functional equivalents, restoring the conditions under which biological self-regulation can resume. Medicine at its best is not smarter than Nature. It is a faithful student of Nature, imitating its methods as accurately as current knowledge allows. We can improve and restore — and that is genuinely valuable — but always within the range that the organism's own biological program defines, not outside it.

What this difference means for problem solving

If reprogramming is framed as reversal of aging itself, the field risks overselling what current evidence can justify. That may distort funding priorities, patient expectations, and translational strategy by implying that systemic rejuvenation is a straightforward bottom-up result of resetting cells.

If reprogramming is framed instead as one tool for improving repair or restoring function within the organism's regulatory boundaries — always in consent with the individual biological program rather than in opposition to it — the research agenda becomes more realistic and potentially more clinically useful. The problem shifts from "how to reset age" to "how to enhance function without violating systemic coherence," which is a more physiological, more honest, and ultimately safer way to translate regenerative science into medicine.

Claim 4: Disease is the main enemy in aging biology

David Sinclair's claim

Sinclair's framework, as presented across his interviews, strongly links aging biology to the burden of chronic disease, and this encourages a view in which aging mechanisms are direct therapeutic targets because they sit upstream of major pathologies. In practice, that can make disease appear mainly as something generated by aging and therefore best defeated by attacking aging mechanisms themselves.

A different reading

This response proposes a different interpretation of disease. Disease should often be understood not simply as an enemy imposed on the organism, but as the organism's own response to etiological disturbance, using the same biological mechanisms it uses in ordinary life: inflammation, compensation, repair, adaptation, and remodeling. In that sense, disease is frequently a disturbed or difficult form of recovery rather than a separate anti-natural process.

That view changes the meaning of medicine. The clinician's role is not merely to suppress disease, but to recognize when the organism's recovery pathway is protective, when it is deviating, and when support, correction, or replacement is necessary. Even advanced interventions such as regenerative therapies imitate Nature's own methods rather than supersede them, because medicine works best when it acts in consent with the organism's regulatory logic rather than against it.

What this difference means for implementation

If disease is approached only as an enemy downstream of aging, interventions may become too focused on eradication and suppression. That can obscure when symptoms or pathological processes are also part of the body's attempt to restore equilibrium, and it may lead to treatment strategies that are effective in the short term but disruptive in the larger physiological context.

If disease is approached as the organism's recovery effort under adverse conditions, implementation becomes more discriminating. The task is to remove etiological harm, guide the reaction back toward productive recovery, and replace failing structures only when the organism's own possibilities are exhausted. This approach is more consistent with a medicine of consent with Nature rather than a medicine of war against life processes.

Claim 5: Aging research should aim at solving the aging problem by biological reversal

David Sinclair's claim

In his interviews, Sinclair presents aging research as a field increasingly able to intervene upstream and perhaps transform the human future by slowing, treating, or reversing aging biology itself. This orientation gives the field urgency and ambition, and it has helped make aging a far more active area of biomedical investigation.

A different reading

The ambition is valuable, but the "problem" may be defined too narrowly if aging itself is treated as the central thing to solve. From the perspective developed here, the true scientific task is to understand how the individual biological program remains coherent from birth to death while immersed in environment, and how medicine can protect that coherence when harmful factors push it off course. Aging then remains one normal phase of life, while the real problem becomes loss of integrity, maladaptation, cumulative damage, and failed recovery within that phase.

This does not weaken aging science. It broadens it. The field becomes not only a search for reversal technologies, but also a science of lifelong physiological continuity, environmental fit, resilience, repair, and individual developmental trajectories.

What this difference means for the field

A reversal-centered science may privilege breakthrough narratives, biomarkers, and platform technologies. A continuity-centered science may produce slower but more comprehensive progress by integrating gerontology, physiology, developmental biology, systems medicine, environmental health, and regenerative medicine into one frame.

The second approach may be especially important for implementation in real populations, because human aging is lived not in laboratories but in persons embedded in nutrition, toxins, social structures, stress, sleep, mobility, and inequality. A science that neglects that wider frame may generate elegant interventions without solving the deeper conditions that shape aging outcomes across the lifespan.

Common conclusion

The difference between Sinclair's reading and the reading developed here is not a difference between science and anti-science. It is a difference between two levels of interpretation. Sinclair emphasizes powerful molecular mechanisms and the possibility of intervention through restoring epigenetic control. The perspective developed here places those mechanisms inside a larger whole-organism vision in which each human being lives one continuous personal biological program from birth to death, always immersed in environment, and aging is one natural phase of that unified life cycle rather than a disease.

That difference matters for every layer of the field. It changes what counts as a cause, what counts as a disease, what an intervention is supposed to achieve, how success is measured, and how far claims should go when moving from cells to persons. It also changes the moral tone of the science: whether medicine is trying to defeat aging, or trying to help persons live their whole biological program with the greatest possible integrity.

A collegial response therefore has to be both warm and explicit. Sinclair's work has real value and has moved aging science forward. At the same time, several declarations in that framework appear overstated: aging is not well described as a disease, epigenetic information loss is not the whole of life's information, and cellular rejuvenation does not straightforwardly equal reversal of the organism's life phase.

Seen this way, the future of geroscience may be strongest when it combines Sinclair's molecular boldness with a fuller respect for Nature's integrative intelligence. That would keep the field ambitious while grounding it in the reality that organisms do not merely age as cells; they live entire lives as persons — and we cannot step into the same river twice. We can only slow, mitigate, and improve the quality of aging, but not truly turn it back into a prior state.

You can learn more by reading our e-books or listening to our audiobooks like this one

 Mykola Iabluchanskyi Yabluchansky